The impacts of cognitive dysfunction in MS patients are extensive, hence its treatment have been an area of focus in recent years. With the rapid growth of COVID-19, MS patients are at a higher risk of cognitive dysfunction and MS specialists need to adapt to monitor MS patients for neuropsychiatric complications and opt for better treatments. Long term effects of the neuropsychiatric complications of this pandemic on the cognitive function and disability status of MS patients is also a subject for future research.